Ferring reports positive outcome from Phase III trials of fertility drug

Swiss biopharmaceutical company Ferring Pharmaceuticals has reported a positive outcome from the Phase III ESTHER-1 and ESTHER-2 clinical trials of its fertility drug, Rekovelle.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news